Cargando…

Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model

BACKGROUND: The prevalence of human infections with the zoonotic pathogen Campylobacter jejuni is rising worldwide. Therefore, the identification of compounds with potent anti-pathogenic and anti-inflammatory properties for future therapeutic and/or preventive application to combat campylobacteriosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mousavi, Soraya, Schmidt, Anna-Maria, Escher, Ulrike, Kittler, Sophie, Kehrenberg, Corinna, Thunhorst, Elisa, Bereswill, Stefan, Heimesaat, Markus M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947993/ https://www.ncbi.nlm.nih.gov/pubmed/31921356 http://dx.doi.org/10.1186/s13099-019-0343-4

Ejemplares similares

Vitamin C alleviates acute enterocolitis in Campylobacter jejuni infected mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Therapeutic Oral Application of Carvacrol Alleviates Acute Campylobacteriosis in Mice Harboring a Human Gut Microbiota
por: Foote, Minnja S., et al.
Publicado: (2023)

Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis
por: Bereswill, Stefan, et al.
Publicado: (2021)

Peroral Clove Essential Oil Treatment Ameliorates Acute Campylobacteriosis—Results from a Preclinical Murine Intervention Study
por: Bereswill, Stefan, et al.
Publicado: (2021)

Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2023)

Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Combination of organic acids benzoate, butyrate, caprylate, and sorbate provides a novel antibiotics-independent treatment option in the combat of acute campylobacteriosis
por: Du, Ke, et al.
Publicado: (2023)

Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine Campylobacter jejuni Infection Model
por: Bereswill, Stefan, et al.
Publicado: (2022)

Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Oral application of carvacrol, butyrate, ellagic acid, and 2′-fucosyl-lactose to mice suffering from acute campylobacteriosis – Results from a preclinical placebo-controlled intervention study
por: Mousavi, Soraya, et al.
Publicado: (2023)

Disease alleviating effects following prophylactic lemon and coriander essential oil treatment in mice with acute campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2023)

Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2021)

Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10(−/−) Mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis—Results from a Preclinical Placebo-Controlled Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2020)

miR-125a-5p regulates the sialyltransferase ST3GAL1 in murine model of human intestinal campylobacteriosis
por: Kraski, Angelina, et al.
Publicado: (2023)

The Host-Specific Intestinal Microbiota Composition Impacts Campylobacter coli Infection in a Clinical Mouse Model of Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Vitamin D in Acute Campylobacteriosis–Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model
por: Mousavi, Soraya, et al.
Publicado: (2019)

Therapeutic Effects of Oral Application of Menthol and Extracts from Tormentil (Potentilla erecta), Raspberry Leaves (Rubus idaeus), and Loosestrife (Lythrum salicaria) during Acute Murine Campylobacteriosis
por: Bandick, Rasmus, et al.
Publicado: (2023)

Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Lactobacillus johnsonii ameliorates intestinal, extra-intestinal and systemic pro-inflammatory immune responses following murine Campylobacter jejuni infection
por: Bereswill, Stefan, et al.
Publicado: (2017)

Protease Activity of Campylobacter jejuni HtrA Modulates Distinct Intestinal and Systemic Immune Responses in Infected Secondary Abiotic IL-10 Deficient Mice
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment
por: Ekmekciu, Ira, et al.
Publicado: (2017)

Modification of Intestinal Microbiota and Its Consequences for Innate Immune Response in the Pathogenesis of Campylobacteriosis
por: Masanta, Wycliffe Omurwa, et al.
Publicado: (2013)

Campylobacter jejuni infection induces acute enterocolitis in IL-10(-/-) mice pretreated with ampicillin plus sulbactam
por: Heimesaat, Markus M., et al.
Publicado: (2022)

Treatment with the Probiotic Product Aviguard(®) Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Immunomodulatory and Antimicrobial Effects of Vitamin C
por: Mousavi, Soraya, et al.
Publicado: (2019)

Curcumin Mitigates Immune-Induced Epithelial Barrier Dysfunction by Campylobacter jejuni
por: Lobo de Sá, Fábia Daniela, et al.
Publicado: (2019)

Antibacterial properties of capsaicin and its derivatives and their potential to fight antibiotic resistance – A literature survey
por: FÜCHTBAUER, SAMUEL, et al.
Publicado: (2021)

Vitamin E as promising adjunct treatment option in the combat of infectious diseases caused by bacterial including multi-drug resistant pathogens – Results from a comprehensive literature survey
por: HARTMANN, MINNJA S., et al.
Publicado: (2020)

Toll-Like Receptor-4 Dependent Inflammatory Responses Following Intestinal Colonization of Secondary Abiotic IL10-Deficient Mice with Multidrug-Resistant Pseudomonas Aeruginosa
por: Grunau, Anne, et al.
Publicado: (2017)

Peroral Low-Dose Toxoplasma gondii Infection of Human Microbiota-Associated Mice — A Subacute Ileitis Model to Unravel Pathogen–Host Interactions
por: Heimesaat, Markus M., et al.
Publicado: (2018)

Review of therapeutic options for infections with carbapenem-resistant Klebsiella pneumoniae
por: BANDICK, RASMUS G., et al.
Publicado: (2020)

The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection
por: GENGER, CLAUDIA, et al.
Publicado: (2020)

Survey of Pathogen-Lowering and Immuno-Modulatory Effects Upon Treatment of Campylobacter coli-Infected Secondary Abiotic IL-10(−/−) Mice with the Probiotic Formulation Aviguard(®)
por: Weschka, Dennis, et al.
Publicado: (2021)

Antimicrobial activity of organic acids against Campylobacter spp. and development of combinations—A synergistic effect?
por: Peh, Elisa, et al.
Publicado: (2020)

Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice
por: Du, Ke, et al.
Publicado: (2022)

Toll-like receptor-4 differentially mediates intestinal and extra-intestinal immune responses upon multi-drug resistant Pseudomonas aeruginosa association of IL10(−/−) mice with chronic colitis
por: Grunau, Anne, et al.
Publicado: (2017)

Multidrug-Resistant Pseudomonas aeruginosa Accelerate Intestinal, Extra-Intestinal, and Systemic Inflammatory Responses in Human Microbiota-Associated Mice With Subacute Ileitis
por: Heimesaat, Markus M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l5jrus1vab7lgiblimrk3mgrka